Evidence for the credibility of health economic models for health policy decision-making: A systematic literature review of screening for abdominal aortic aneurysms

Journal of Health Services Research and Policy

Volumn 17, Issue 1, 2012, Pages 44-52

  Søgaard, Rikke ^a   Lindholt, Jes ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; COST EFFECTIVENESS ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; NONBIOLOGICAL MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW;

AORTIC ANEURYSM, ABDOMINAL; DECISION MAKING; HEALTH POLICY; HUMANS; MODELS, ECONOMIC; POLICY MAKING;

EID: 84856304556     PISSN: 13558196     EISSN: None     Source Type: Journal    
DOI: 10.1258/jhsrp.2011.010133     Document Type: Review

References (30)

1. Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment. Pharmacoeconomics 2000;17:443-44
2. NICE. Guide to the methods of technology appraisal. London: NICE, 2004
3. NICE. Guide to the methods of technology appraisal. London: NICE, 2008
4. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics 2000;17:461-77 (Pubitemid 30398805)
5. Campbell H, Briggs A, Buxton M, et al. The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. J Health Serv Res Policy 2007;12:11-17 (Pubitemid 46174200)
6. Ehlers L, Sorensen J, Jensen LG, et al. Is population screening for abdominal aortic aneurysm cost-effective? BMC Cardiovasc Disord 2008;8:32
7. Department of Health. Impact assessment of a national screening programme for abdominal aortic aneurysms. 5th ed. London: Department of Health, 2008
8. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 2005;142:198-202
9. Cooper NJ, Sutton AJ, Ades AE, et al. Use of evidence in economic decision models: practical issues and methodological challenges. Health Econ 2007;16:1277-86
10. Ehlers L, Overvad K, Sorensen J, et al. Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm. BMJ 2009;338:b2243
11. Kim LG, Thompson SG, Briggs AH, et al. How cost-effective is screening for abdominal aortic aneurysms? J Med Screen 2007;14:46-52 (Pubitemid 46440366)
12. Meenan R, Fleming C, Whitlock EP, et al. Cost-effectiveness analyses of population-based screening for abdominal aortic aneurysm: evidence synthesis. Report of the US Preventive Service Task Force Guide to Clinical Preventive Services. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality, 2005
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535
14. Philips Z, Bojke L, Sculpher M, et al. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006;24:355-71
15. Silverstein MD, Pitts SR, Chaikof EL, Ballard DJ. Abdominal aortic aneurysm (AAA): cost-effectiveness of screening, surveillance of intermediate-sized AAA, and management of symptomatic AAA. Proc (Bayl Univ Med Cent) 2005;18:345-67
16. Wanhainen A, Lundkvist J, Bergqvist D, Bjorck M. Cost-effectiveness of different screening strategies for abdominal aortic aneurysm. J Vasc Surg 2005;41:741-51 (Discussion 51)
17. Mani K, Alund M, Bjorck M, et al. Screening for abdominal aortic aneurysm among patients referred to the vascular laboratory is cost-effective. Eur J Vasc Endovasc Surg 2010;39:208-16
18. Montreuil B, Brophy J. Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates. Can J Surg 2008;51:23-34
19. Henriksson M, Lundgren F. Decision-analytical model with lifetime estimation of costs and health outcomes for one-time screening for abdominal aortic aneurysm in 65-year-old men. Br J Surg 2005;92:976-83 (Pubitemid 41160787)
20. Kim LG, Thompson S, Buxton M, et al. A Markov model for long-term cost-effectiveness modelling of screening for abdominal aortic aneurysms. Cambridge: MRC Biostatistics Unit, 2006
21. Henriksson M, Lundgren F. One-time screening of abdominal aortic aneurysm in 65 year old men - a descision-analytic model with lifetime estimation of costs and health outcomes. Technical Report. Linköping: Centre for Medical Technology Assessment, Linköping University, 2005
22. Kim LG, Thompson SG. Uncertainty and validation of health economic decision models. Health Econ 2010;19:43-55
23. Ashton HA, Buxton MJ, Day NE, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531-39 (Pubitemid 35356366)
24. Kim LG, Ra PS, Ashton HA, Thompson SG. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007;146:699-706 (Pubitemid 351639997)
25. Lederle FA, Johnson GR, Wilson SE, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002;287:2968-72 (Pubitemid 34620000)
26. Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 1999;230:289-96; discussion 96-97
27. Briggs AH, Claxton K, Sculpher MJ. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006
28. Thompson S, Kim L, Gao L. Abdominal aortic aneurysm: Comparing studies for cost effectiveness of screening. BMJ 2009;339:63044
29. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. Pharmacoeconomics 2006;24:1055-68 (Pubitemid 44683363)
30. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005;14:339-47 (Pubitemid 40514748)